Hypertension (high blood pressure) Board decisions

The Board remands the claims for service connection for diabetes mellitus type II and hypertension to obtain a VA opinion regarding whether obesity may be an intermediate step between the Veteran's service-connected acquired psychiatric disability and his claimed disabilities.

The Veteran withdrew the appeals for an increase rating for IBS and service connection for hypertension.

The Board denied service connection for hypertension, genital herpes, and psoriasis as the evidence did not support a finding that these conditions were incurred or aggravated during active duty for training (ADT) or considered to be an injury incurred during inactive duty for training (IDT).

The Board granted a 10 percent disability rating for hypertension and remanded the claim for service connection for stroke and residuals thereof.

The Board denied service connection for bipolar disorder, hypertension as secondary to PTSD, anxiety disorder and hypochondria, tinnitus, and posttraumatic stress disorder (PTSD) due to insufficient evidence of a current diagnosis or nexus to service.

The Veteran's service-connected PTSD and MDD have rendered him unemployable, effective March 9, 2023.

The Board remands the claims for service connection for various disabilities, including diabetes mellitus, thyroid disability, coronary artery disease, hypertension, erectile dysfunction, sinus disability, bilateral flat feet, right and left knee disabilities, and right and left lower extremity radiculopathy, to correct pre-decisional duty-to-assist errors.

The Board denied service connection for hypertension as it is not related to the Veteran's active service or any incident therein.

The Board denied the Veteran's claim for an increased rating for hypertension, as there was no evidence of diastolic pressure predominantly 120 or more during the appeal period.

The Board denied entitlement to an earlier effective date for the award of service connection for diabetes mellitus and hypertension, as well as a compensable disability rating for bilateral hearing loss.

The Board denied the veteran's claims for an initial compensable rating for hypertension and a higher disability evaluation for MDS, as well as remanded service connection claims for bilateral hearing loss and tinnitus.

The Board denied service connection for hypertension, finding that the evidence did not support a link between the Veteran's hypertension and his military service.

The Board denied the veteran's claims for increased ratings, TDIU, and service connection for various conditions, including heart disease, diabetes mellitus type II, hypertension, stroke residuals, right knee disorder, left knee disorder, and a seizure disorder.

The Board remands the claims for service connection for a headache condition, varicose veins, a bilateral eye disability, and hypertension on a direct basis due to inadequate medical opinions.

The Board remands the claims for service connection for hypertension, degenerative disease of the cervical spine (claimed as neck pain), and lumbosacral strain (claimed as lower back injury) to obtain additional evidence and an adequate medical opinion.

The Board denied a rating in excess of 50 percent for PTSD prior to March 29, 2024 and denied TDIU.

The Board remands the issues of entitlement to an increased rating for right knee degenerative arthritis and chondromalacia, service connection for hypertension, stroke, and coronary heart disease, as additional evidence has been submitted outside the allowed time frame.

The Board denied a rating in excess of 50 percent for sleep apnea with allergic bronchial asthma, granted an initial 10 percent rating for allergic rhinitis, and denied a compensable rating for bilateral hearing loss. The hypertension claim was remanded.

The Board granted service connection for an unspecified depressive disorder and tension headaches but denied the claim for hypertension.

The Board granted service connection for a right knee condition and left knee condition, but denied service connection for hypertension. The decision also addressed various claims related to increased ratings and effective dates.